Graft Versus Host Disease Treatment News and Information

What is Graft Versus Host Disease ?

According to the U.S. National Library of Medicine, Graft-versus-host disease (GVHD) is a complication which can occur following stem cell or bone marrow transplants in which the affected person receives bone marrow tissue or cells from a donor. This type of transplant is called allogeneic. The new, transplanted cells react to the recipient’s body as foreign. When this happens, the cells attack the recipient’s body.

See below for updated news and information regarding Graft Versus Host Disease including new medical research, treatment options and advancements. 

Latest Graft Versus Host Disease Treatment News and Research

Graft Versus Host Disease Treatment News (GVHD): Moffitt Cancer Center Researchers Develop Novel Treatment to Prevent Graft-Versus-Host-Disease

(SOURCE: H. LEE MOFFITT CANCER CENTER & RESEARCH INSTITUTE) - Graft-versus-host-disease (GVHD) is the leading cause of non-relapse associated death in patients who receive stem cell transplants.  In a new study published as the cover story in Science Translational Medicine, Moffitt Cancer Center researchers show that a novel treatment can effectively inhibit the development of GVHD in mice and maintain the infection- ...
Read More